PepGen Inc. Faces Class Action Lawsuit Over Securities Fraud Claims: Investor Information Inside

Introduction

PepGen Inc., a company listed on NASDAQ under the ticker PEPG, is currently facing serious allegations of securities fraud, leading to a class action lawsuit filed by investors. The legal action, announced by Levi & Korsinsky, LLP, is significant for anyone who has invested in PepGen during a specified timeframe, focusing particularly on losses incurred between March 7, 2024, and March 3, 2025. If you believe you have been affected by these allegations, understanding your rights and the legal options available is crucial.

Nature of the Allegations

The lawsuit claims that PepGen made false statements about its lead product candidate, PGN-EDO51. It's asserted that the product was less effective and posed safety concerns that were not disclosed to investors. Additionally, it is alleged that a clinical study known as the CONNECT2 study was flawed and insufficiently designed to meet the standards set by the U.S. Food and Drug Administration (FDA). These claims suggest that PepGen misled investors regarding the viability and prospects of PGN-EDO51, resulting in inflated public statements about the company’s potential. Consequently, the allegations have raised serious questions about the integrity of PepGen’s communications with shareholders.

Investor Rights and Participation

Affected investors need to act swiftly, as they have until August 8, 2025, to submit a request for the court to appoint them as lead plaintiff in the lawsuit. However, it is important to note that you do not have to be a lead plaintiff to qualify for potential recoveries from any settlement. Investors can seek recovery without incurring out-of-pocket expenses, as participation in this class action carries no cost or obligation.

For those interested in learning more or wanting to become involved, Levi & Korsinsky encourages contacting their legal team. Investors may reach out via email or phone to discuss their options and rights in detail. The firm possesses extensive experience in complex securities litigation, and over the years, it has secured significant sums for aggrieved shareholders.

Why Choose Levi & Korsinsky?

Having a trusted legal partner is vital when navigating the complexities of securities lawsuits. Levi & Korsinsky has a noteworthy track record in representing investors, and its team has garnered a reputation for successfully managing high-stakes cases. Ranked among the top firms in securities litigation, they are well-equipped to advocate for investor rights in this challenging situation.

Conclusion

As this class action lawsuit unfolds, investors in PepGen Inc. are encouraged to stay informed and proactive regarding their rights. If you have been impacted by the alleged fraud, consider reaching out to legal professionals who specialize in securities law. Participation in the class action could potentially lead to financial recovery without incurring costs, allowing investors to seek justice for their losses in a straightforward manner.

For further information and assistance related to the class action lawsuit, investors can visit the Levi & Korsinsky website or contact the firm directly. Stay vigilant and informed as this situation develops.